CVS Health (CVS) Tops Q2 EPS by 35c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $87.60 -1.4%
EPS Growth %: +2.5%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +2.5%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $1.81, $0.35 better than the analyst estimate of $1.46. Revenue for the quarter came in at $98.9 billion versus the consensus estimate of $94.73 billion.
GUIDANCE:
CVS Health sees FY2025 EPS of $6.30-$6.40, versus the consensus of $6.12.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Iambic Therapeutics (IAM) files for proposed IPO
- Paramount Skydance extends debt offer deadlines to October 2
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
